Arca biopharma announces third quarter 2022 financial results

Company is currently engaged in a strategic review process, evaluating additional development of its assets, collaborations and other strategic options company is currently engaged in a strategic review process, evaluating additional development of its assets, collaborations and other strategic options
ABIO Ratings Summary
ABIO Quant Ranking